Eli Lilly and Co (LLY)
734.97
-20.94
(-2.77%)
USD |
NYSE |
May 03, 16:00
738.49
+3.52
(+0.48%)
After-Hours: 20:00
Eli Lilly PE Ratio: 110.09 for May 3, 2024
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| May 03, 2024 | 110.09 |
| May 02, 2024 | 113.22 |
| May 01, 2024 | 116.34 |
| April 30, 2024 | 117.00 |
| April 29, 2024 | 110.42 |
| April 26, 2024 | 109.87 |
| April 25, 2024 | 108.57 |
| April 24, 2024 | 109.67 |
| April 23, 2024 | 111.69 |
| April 22, 2024 | 109.54 |
| April 19, 2024 | 108.79 |
| April 18, 2024 | 111.73 |
| April 17, 2024 | 112.45 |
| April 16, 2024 | 111.85 |
| April 15, 2024 | 112.45 |
| April 12, 2024 | 112.58 |
| April 11, 2024 | 113.77 |
| April 10, 2024 | 114.13 |
| April 09, 2024 | 113.42 |
| April 08, 2024 | 116.42 |
| April 05, 2024 | 117.46 |
| April 04, 2024 | 115.04 |
| April 03, 2024 | 116.23 |
| April 02, 2024 | 114.43 |
| April 01, 2024 | 113.92 |
| Date | Value |
|---|---|
| March 31, 2024 | 116.52 |
| March 28, 2024 | 136.81 |
| March 27, 2024 | 136.85 |
| March 26, 2024 | 136.27 |
| March 25, 2024 | 135.96 |
| March 22, 2024 | 135.52 |
| March 21, 2024 | 135.46 |
| March 20, 2024 | 135.92 |
| March 19, 2024 | 135.90 |
| March 18, 2024 | 134.12 |
| March 15, 2024 | 132.63 |
| March 14, 2024 | 133.78 |
| March 13, 2024 | 133.27 |
| March 12, 2024 | 132.77 |
| March 11, 2024 | 129.15 |
| March 08, 2024 | 134.03 |
| March 07, 2024 | 137.20 |
| March 06, 2024 | 137.13 |
| March 05, 2024 | 136.75 |
| March 04, 2024 | 139.33 |
| March 01, 2024 | 137.54 |
| February 29, 2024 | 132.54 |
| February 28, 2024 | 133.24 |
| February 27, 2024 | 134.53 |
| February 26, 2024 | 135.75 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
13.06
Minimum
Oct 10 2019
139.33
Maximum
Mar 04 2024
46.33
Average
39.60
Median
PE Ratio Benchmarks
| Amgen Inc | 44.47 |
| Biogen Inc | 27.15 |
| Madrigal Pharmaceuticals Inc | -- |
| Vertex Pharmaceuticals Inc | 28.88 |
| Viking Therapeutics Inc | -- |
PE Ratio Related Metrics
| PS Ratio | 18.46 |
| PEG Ratio | 13.99 |
| Price to Book Value | 54.52 |
| Price | 734.97 |
| Earnings Yield | 0.91% |
| Market Cap | 698.52B |
| PEGY Ratio | 12.94 |
| Operating PE Ratio | 55.10 |
| Normalized PE Ratio | 72.50 |